IR HOME NEWS & EVENTS OVERVIEW PRESS RELEASES EVENTS & PRESENTATIONS STOCK INFORMATION OVERVIEW HISTORIC STOCK LOOKUP INVESTMENT CALCULATOR ANALYST COVERAGE FINANCIALS & FILINGS OVERVIEW SEC FILINGS CORPORATE GOVERNANCE OVERVIEW LEADERSHIP BOARD OF DIRECTORS COMMITTEE COMPOSITION CONTACT IR IR HOME NEWS & EVENTS OVERVIEW PRESS RELEASES EVENTS & PRESENTATIONS STOCK INFORMATION OVERVIEW HISTORIC STOCK LOOKUP INVESTMENT CALCULATOR ANALYST COVERAGE FINANCIALS & FILINGS OVERVIEW SEC FILINGS CORPORATE GOVERNANCE OVERVIEW LEADERSHIP BOARD OF DIRECTORS COMMITTEE COMPOSITION CONTACT IR Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024 Read more about Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024 Ardelyx, Inc. Reports Employment Inducement Grants Read more about Ardelyx, Inc. Reports Employment Inducement Grants Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy Read more about Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy Ardelyx, Inc. Reports Employment Inducement Grants Read more about Ardelyx, Inc. Reports Employment Inducement Grants Ardelyx to Participate at the Cowen 44th Annual Health Care Conference Read more about Ardelyx to Participate at the Cowen 44th Annual Health Care Conference Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update Read more about Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update Ardelyx to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024 Read more about Ardelyx to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024 Ryan Deschner, Ph.D. Ryan Deschner, Ph.D. Raymond James Ardelyx, Inc. Reports Employment Inducement Grants Read more about Ardelyx, Inc. Reports Employment Inducement Grants Ardelyx Provides Update on Growing Commercial Momentum and 2024 Strategic Priorities Read more about Ardelyx Provides Update on Growing Commercial Momentum and 2024 Strategic Priorities Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last » Subscribe to FAQs Email Alerts Connect
Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024 Read more about Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024
Ardelyx, Inc. Reports Employment Inducement Grants Read more about Ardelyx, Inc. Reports Employment Inducement Grants
Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy Read more about Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy
Ardelyx, Inc. Reports Employment Inducement Grants Read more about Ardelyx, Inc. Reports Employment Inducement Grants
Ardelyx to Participate at the Cowen 44th Annual Health Care Conference Read more about Ardelyx to Participate at the Cowen 44th Annual Health Care Conference
Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update Read more about Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Ardelyx to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024 Read more about Ardelyx to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
Ardelyx, Inc. Reports Employment Inducement Grants Read more about Ardelyx, Inc. Reports Employment Inducement Grants
Ardelyx Provides Update on Growing Commercial Momentum and 2024 Strategic Priorities Read more about Ardelyx Provides Update on Growing Commercial Momentum and 2024 Strategic Priorities